title: Are PALB2 mutations associated with increased risk of male breast cancer?
authors.forename: A
authors.initials: A
authors.lastname: Sauty de Chalon
authors.forename: Z
authors.initials: Z
authors.lastname: Teo
authors.forename: D J
authors.initials: DJ
authors.lastname: Park
authors.forename: F A
authors.initials: FA
authors.lastname: Odefrey
authors.forename: J L
authors.initials: JL
authors.lastname: Hopper
authors.forename: M C
authors.initials: MC
authors.lastname: Southey
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000595:Amino Acid Sequence; D018567:Breast Neoplasms, Male / Q000235:genetics*; D000076164:Fanconi Anemia Complementation Group N Protein; D005260:Female; D020022:Genetic Predisposition to Disease; D018095:Germ-Line Mutation; D006801:Humans; D008297:Male; D008875:Middle Aged; D009687:Nuclear Proteins / Q000235:genetics*; D010375:Pedigree; D012307:Risk Factors; D025521:Tumor Suppressor Proteins / Q000235:genetics*
chemical_list: D000076164:Fanconi Anemia Complementation Group N Protein; D009687:Nuclear Proteins; C512790:PALB2 protein, human; D025521:Tumor Suppressor Proteins